Role of GATA-1 in normal and neoplastic hemopoiesis

Annals of the New York Academy of Sciences

Volumn 1044, Issue , 2005, Pages 142-158

  Migliaccio, Anna Rita ^a,b   Rana, Rosa Alba ^b   Vannucchi, Alessandro M ^c   Manzoli, Francesco A ^d  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

GATA 1; Idiopathic myelofibrosis; Megakaryocytes; Mouse model of human diseases

Indexed keywords

TRANSCRIPTION FACTOR GATA 1;

BINDING SITE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; EOSINOPHIL; ERYTHROID CELL; ERYTHROLEUKEMIA; ERYTHROPOIESIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCUS; GENE SEQUENCE; GENE TARGETING; GENETIC ENGINEERING; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; MAST CELL; MEGAKARYOCYTE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; THROMBOCYTOPENIA; TRANSCRIPTION INITIATION;

EID: 22044440344     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1349.019     Document Type: Conference Paper

References (87)

1. ORKIN, S.H. 2000. Transcription factors that regulate lineage decisions. In The Molecular Basis of Blood Diseases. G. Stamatoyannopoulous, Ed.: 80-120. Saunders. Philadelphia.
2. TSAI, S.F., M. DIK, Z. LI, et al. 1989. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 339: 446-451.
3. CHIBA, T., Y. IKAWA & K. TODOKORO. 1991. GATA-1 transactivates the erythropoietin receptor gene and erythropoietin receptor-mediated signalling enhance GATA-1 expression. Nucleic Acid Res. 19: 3843-3848.
4. ZON LI, H. YOUSSOUFIAN, C. MATHER, et al. 1991. Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc. Natl. Acad. Sci. USA 88: 10638-10641.
5. DIK, M., L.I. ZON, G. MUTTER, et al. 1990. Expression of an erythroid transcription factor in megakaryocytic ad mast cell lineages. Nature 344: 444-447.
6. ROMEO, P.H., M.H. PRANDINI, V. JOULIN, et al. 1990. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature 344: 447-449.
7. YU, C., A.B. CANTOR, H. YANG, et al. 2002. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J. Exp. Med. 195: 1387-1395.
8. MIGLIACCIO, A.R., R.A. RANA, M. SANCHEZ, et al. 2003. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1 low mouse mutant. J. Exp. Med. 197: 281-296.
9. ITO, E., T. TOKI, H. ISHIHARA, et al. 1993. Erythroid transcription factor GATA-1 is abundantly transcribed in mouse testis. Nature 362: 466-468.
10. TRAINOR, C.D., T. EVANS, G. FELSENFELD, et al. 1990. Structure and evolution of a human erythroid transcription factor. Nature 343: 92-96.
11. CANTOR, A.B. & S.H. ORKIN. 2002. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 21: 3368-3376.
12. TSAI, F.Y., C.P. BROWNE & S.H. ORKIN. 1998. Knock-in mutation of transcription factor GATA-3 into the GATA-1 locus: partial rescue of GATA-1 loss of function in erythroid cells. Dev. Biol. 196: 218-227.
13. KULESSA, H., J. FRAMPTON & T. GRAF. 1995. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev. 9: 1250-1262.
14. FARINA, S.F., L.J. GIRARD, E.F. VANIN, et al. 1995. Dysregulated expression of GATA-1 following retrovirus-mediated gene transfer into murine hematopoietic stem cells increases erythropoiesis. Blood 86: 4124-4133.
15. McNagny, K. & T. Graf. 2002. Making eosinophils through subtle shifts in transcription factor expression. J. Exp. Med. 195: 43-47.
16. CROTTA, S., S. NICOLIS, A. RONCHI, et al. 1990. Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines. Nucleic Acids Res. 18: 6863-6869.
17. ASHIHARA, E., A.M. VANNUCCHI, G. MIGLIACCIO & A.R. MIGLIACCIO. 1997. Growth factor receptor expression durino in vitro differentiation of purified populations containing murine stem cells. J. Cell Physiol. 171: 343-356.
18. TERSKIKH, A. V., T. MYAMOTO, C. CHANG, et al. 2003. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 102: 94-101.
19. MORONI, E., L. CAIRNS, S. OTTOLENGHI, et al. 1997. Expression in hematopoietic cells of GATA-1 transcripts from the alternative "Testis" promoter during development and cell differentiation. Biochem. Biophys. Res. Comm. 231: 299-304.
20. VANNUCCHI, A.M., S. LINARI, C.S. LIN, et al. 1999. Increased expression of the distal, but not of the proximal, Gata-1 transcripts during differentiation of primary erythroid cells. J. Cell Phys. 180: 390-401.
21. VANNUCCHI, A.M., F. PAOLETTI, S. LINARI, et al. 2000. Identification and characterization of a bipotent (erythroid and megakaryocyte) cell precursor from the spleen of phenylhydrazine-treated mice. Blood 95: 2559-2568.
22. VALVERDE-GARDUNO, V, B. GUYOT, E. ANGUITA, et al. 2004 Differences in chromatin structure and cis-element organization of the human and mouse GATA-1 loci: implications doe cis-element identification. Blood 104: 3106-3116.
23. MCDEVITT, M.A., R.A. SHIVDASANI, Y. FUJIWARA, et al. 1997. A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc. Natl. Acad. SCi. USA 94: 6781-6785.
24. TAKAHASHI, S., K. ONEDERA, H. TOHASHI, et al. 1997. Arrest in primitive erythroid cell development caused by promoter-specific disruption of the GATA-1 mice. J. Biol. Chem. 272: 12611-12615.
25. RONCHI, A., M. CIRÒ, L. CAIRNS, et al. 1997. Molecular heterogeneity of regulatory elements of the mouse GATA-1 gene. Genes Function 1: 245-258.
26. SHIVDASANI, R.A., Y. FUJIWARA, M.A. MCDEVITT, et al. 1997. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 16: 3965-3973.
27. VYAS, P., K. AULT, C.W. JACKSON, et al. 1999. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 93: 2867-2875.
28. VYAS, P., M.A. MCDEVITT, A.B. CANTOR, et al. 1999. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development 126: 2799-2811.
29. GUYOT, B., V. VALVERDE-GARDUNO, C. PORCHER, et al. 2004. Deletion of the major enhancer HS 1 does not affect eosinophil GATA-1 expression and eosinophil differentiation. Blood 104: 89-91.
30. WADMAN, I.A., H. OSADA, G.G. GRUTZ, et al. 1997. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid DNA-binding complex which includes the TALI, E47, GATA-1 and Ldb1/NL1 proteins. EMBO J 16: 3145-3157.
31. VISVADER, J.E., M. CROSSLEY, J. HILL, et al. 1995. The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line. Mol. Cell Biol. 15: 634-641.
32. SHIMIZU, R., S. TAKAHASHI & K. OHNEDA. 2001. In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis. EMBO J. 20: 5250-5260.
33. CANTOR, A.B., S.G. KATZ & S.H. ORKIN. 2002. Distinct domains of the GATA-1 cofactor FOG-1 differentially influence erythroid versus megakaryocytic maturation. Mol. Cell Biol. 22: 4268-4279.
34. TANG, A.P., J.E. VISVADER, C.A. TURNER, et al. 1997. FOG, a multiple zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90: 109-119.
35. CHANG, A.N., A.B. CANTOR, Y. FUJIWARA, et al. 2002. GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc. Natl. Acad. Sci. USA 99: 9237-9242.
36. NICHOLS, K.E., J.D. CRISPINO, M. PONCZ, et al. 2000. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat. Genet. 24: 266-270.
37. MEHAFFEY, M.G., A.L. NEWTON, M.J. GANDHI, et al. 2001. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood 98: 2681-2688.
38. YU, C., K.K. NIAKAN, M. MATSUSHITA, et al. 2002. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood 100: 20402045.
39. FRESON, K., K. DEVRIENDT, G. MATTHIJS, et al. 2001. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood 98: 85-92.
40. ZHANG, P., X. ZHANG, A. IWAMA, et al. 2000. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 96: 2641-2648.
41. FUJIWARA, Y., A.N. CHANG, A.M. WILLIAMS, et al. 2004. Functional overlap of GATA-1 and GATA-2 in primitive hematopoietic development. Blood 103: 583-585.
42. FUJIWARA, Y., C.P. BROWNE, K. CUNNIFF, et al. 1996. Arrested development of embryonic red cell precursors in mouse embryos lacking transcriptional factor GATA-1. Develop. Biol. 93: 12355-12358.
43. PEVNY, L., C.S. LIN, V. D'AGATI, et al. 1995. Development of hematopoietic cells lacking transcription factor GATA-1. Development 121: 163-172.
44. low mice). Blood 97: 3040-3050.
45. SOCOLOVSKY, M., H-S NAM, M.D. FLEMING, et al. 2001. Ineffective erythropoiesis in STAT5a-/-5b-/- mice due to decreased survival of early erythroblasts. Blood 98: 3261-3273.
46. HARDER, K.W., C. QUILICI, E. NAIK, et al. 2004. Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. Blood August 31, 2004 (prepublished online).
47. WESSELY, O., E.M. DEINER, H. BEUG, et al. 1997. The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors. EMBO J. 16: 267-280.
48. HUMBLES, A.A., C.M. LLOYD, S.J. MCMILLAN, et al. 2004. A critical role for eosinophils in allergic airways remodeling. Science 305: 1726-1779.
49. KAUSHANSKY, K. 1995. Thrombopoietin: the primary regulator of platelet production. Blood 86: 419-431.
50. low mice. Blood 104: 3573-3579.
51. SPERANDIO, S., I. DE BELLE & D.E. BREDESEN. 2000. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA 97: 14376-14381.
52. HOUWERZIJL, E.J., N.R. BLOM, J.J. VAN DER WANT, et al. 2004. Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood 103: 500-506.
53. ZUCKER-FRANCKLIN, D. 1975. Ultrastructural studies of hematopoietic elements in relation to the myelofibrosis-osteosclerosis syndrome, megakaryocytes and platelets (MMM or MOS). In Dahlem Workshop on Myelofibrosis-Osteosclerosis Syndrome. R.C.C. Burkhardt, K. Lennert, S.S. Adler, et al., Eds.: 127-143. Pergamon. Dahlem, West Germany.
54. CASHELL, A.W. & D.H. BUSS. 1992. The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states. Ann. Hematol. 64: 273-276.
55. THIELE, J., J. LORENZEN, B. MANICH, et al. 1997. Apoptosis (programmed cell death) in idiopathic (primary) osteo-/myelofibrosis: naked nuclei in megakaryopoiesis reveal features of para-apoptosis. Acta Haematol. 97: 137-143.
56. SCHMITT, M.A., H. JOUAULT, J. GUICHARD, et al. 2000. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood 96: 1342-1347.
57. HOFFMAN, R. 2000. Agnogenic myeloid metaplasia. In Basic principles and practice. R. Hoffman, E.J. Benz, S.J. Shattil, et al., Eds.: 1172-1188. Hematology. Churchill Livingstone. New York.
58. TEFFERI, A. 2000. Myelofibrosis with myeloid metaplasia. N. Engl. J. Med. 342: 1255-1265.
59. YAN, X.Q., D. LACEY, F. FLETCHER, et al. 1995. Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 86: 4025-4033.
60. YAN, X.Q., D. LACEY, D. HILL, et al. 1996. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood 88: 402-409.
61. GUARDIOLA, P., H. ESPEROU, D. CAZALS-HATEM, et al. 1997. Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow Transplantation. Br. J. Haematol. 98: 1004-1009.
62. DEVINE, S.M., R. HOFFMAN, A. VERMA, et al. 2002. Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood 99: 2255-2258.
63. DEEG, H.J., T.A. GOOLEY, M.E. FLOWERS, et al. 2003. Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Blood 102: 3912-3918.
64. XU, M.J., E. BRUNO, G. BAROSI, et al. 2004. The constitutive mobilization of bone marrow repopulating cells into peripheral blood in Idiopathic Myelofibrosis. Blood October 7, 2004 (prepublished online).
65. BAROSI, G., G. VIARENGO, A. PECCI, et al. 2001. Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 98: 3249-3255.
66. PASTORE, C., J. NOMDEDEU, G. VOLPE, et al. 1995. Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders. Genes Chromosomes Cancer 14: 106-111.
67. REILLY, J.T., J.A. SNOWDEN, R.L. SPEARINGM, et al. 1997. Cytogentic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. Br. J. Haematol. 98: 96-102.
68. VANNUCCHI, A.M., L. BIANCHI, C. CELLAI, et al. 2002. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low)mice). Blood 100: 1123-1132.
69. ZHOU, W., C.F. TOOMBS, T. ZOU, et al. 1997. Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment. Blood 89: 1551-1559.
70. MARTYRE, M.C., V. STEUNOU, M.C. LEBOUSSE-KERDILÈS, et al. 2003. Lack of alterations in GATA-1 expression in CD34+ hematopoietic progenitors from patients with idiopathic myelofibrosis. Blood 101: 5087-5089.
71. VANNUCCHI, A.M., L. BIANCHI, A. PANCRAZZI, et al. 2003. Reduced GATA-1 content in megakaryocytes of patients with idiopathic myelofibrosis [Abstract]. Blood 102: 2457.
72. low mutation in mice [Abstract]. Blood 100: 533.
73. PAPAYANNOPOULOU, T. 2003. Bone marrow homing: the players, the playfield, and their evolving roles. Curr. Opin. Hematol. 10: 214-219.
74. MARTYRE, M.C., N. ROMQUIN, M.C. LE BOUSSE-KERDILES, et al. 1994. Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br. J. Haematol. 88: 9-16.
75. LE BOUSSE-KERDILES, M.C., S. CHEVILLARD, A. CHARPENTIER, et al. 1996. Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood 88: 4534-4546.
76. Chagraoui, H., E. Komura, M. Tulliez, et al. 2002. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood 100: 3495-3503.
77. YANAGIDA, M., Y. IDE, A. IMAI, et al. 1997. The role of transforming growth factor-beta in PEG-rHuMGDF-induced reversible myelofibrosis in rats. Br. J. Haematol. 99: 739-745.
78. HOLT, S.E., J.W. SHAY & W.E. WRIGHT. 1996. Refining the telomere-telomerase hypothesis of aging and cancer. Nat. Biotechnol. 14: 836-839.
79. VAZIRI, H., W. DRAGOWSKA, R.C. ALLSOPP, et al. 1994. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 91: 9857-9860.
80. GRASS, J.A., M.E. BOYER, S. PAL, et al. 2003. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc. Natl. Acad. Sci. USA 100: 8811-8816.
81. MIGLIACCIO, A.R., Y. JIANG, G. MIGLIACCIO, et al. 1993. Transcriptional and posttranscriptional regulation of the expression of the erythropoietin receptor gene in human erythropoietin-responsive cell lines. Blood 82: 3760-3769.
82. NIJHOF, W., P.K. WIERENGA, J. PIETENS, et al. 1984. Cell kinetic behaviour of a synchronized population of erythroid precursor cells in vitro. Cell Tissue Kinet. 17: 629-639.
83. PAL, S., A.B. CANTOR, K.D. JOHNSON, et al. 2004. Coregulator-dependent facilitation of chromatin occupancy by GATA-1. Proc. Natl. Acad. Sci. USA 101: 980-985.
84. SHIMIZU, R., O. OHNEDA, T. KUROHA, et al. 2003. Leukemogenesis caused by the incompetence of GATA-1 function [Abstract]. GATA meeting. Montreal: 15.
85. WECHSLER, J., M. GREENE, M.A. MCDEVITT, et al. 2002. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat. Genet. 32: 148-152.
86. AHMED, M., A. STERNBERG, G. HALL, et al. 2004. Natural history of GATA1 mutations in Down syndrome. Blood 103: 2480-2489.
87. HARIGAE, H., G. XU, T. SUGAWARA, et al. 2004. The GATA-1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome. Blood 103: 3242-3243.